LETROW 5 mg / 50 Tabs contains letrozole, a nonsteroidal aromatase inhibitor that works by reducing the body's production of estrogen. Letrozole is an established prescription medicine used in the management of certain hormone-receptor-positive breast cancers, particularly in postmenopausal women.
At Pharmapeplabs, LETROW 5 mg / 50 Tabs can be presented as a convenient tablet formulation for customers seeking information about letrozole-based prescription treatment. Each tablet is listed as containing 5 mg of letrozole, with a package size of 50 tablets.
- Product: LETROW
- Active ingredient: Letrozole
- Strength: 5 mg per tablet
- Pack size: 50 tablets
- Drug class: Nonsteroidal aromatase inhibitor
- Form: Oral tablets
- Primary medical use: Management of certain hormone-dependent breast cancers under medical supervision
Letrozole inhibits the aromatase enzyme, reducing estrogen biosynthesis. Lowering estrogen can help slow or stop the growth of some breast cancer cells that depend on estrogen.
LETROW should be used only under the direction of a qualified healthcare professional. Letrozole can cause side effects including hot flushes, joint or bone pain, fatigue, nausea, dizziness, and changes in bone mineral density. It may also increase the risk of osteoporosis and fractures.
Pharmapeplabs recommends consulting a physician or pharmacist before using letrozole, particularly if you have liver disease, osteoporosis, high cholesterol, or are taking other prescription medicines.

Reviews
There are no reviews yet.